Long-Term Follow-Up Confirms Benefits of Low-Dose Seminoma TreatmentBySabrina SeraniNovember 15th 2025
Rethinking Advanced Prostate Cancer: Surprising Finds from a Landmark Study BySabrina SeraniNovember 14th 2025
How Resting Immune Cells Could Be the Key to Fighting Prostate CancerBySabrina SeraniNovember 14th 2025
FDA Approves Novel Interchangeable Biosimilar for Pertuzumab in HER2+ Breast CancerBySabrina SeraniNovember 13th 2025